Rutjes, Chantal
Torrano, Joachim
Soyer, H. Peter
Funding for this research was provided by:
The University of Queensland
Article History
Accepted: 21 December 2021
First Online: 14 January 2022
Declarations
:
: H. P. Soyer is a shareholder of MoleMap NZ Limited and e‑derm consult GmbH, and undertakes regular teledermatological reporting for both companies. He is a medical consultant for Canfield Scientific Inc., Blaze Bioscience Inc., MoleMap Australia Pty Limited, and a Medical Advisor for First Derm and Revenio Research Oy. C. Rutjes and J. Torrano declare that they have no competing interests.
: This article does not contain any studies with human participants or animals performed by any of the authors.